Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Jefferies Downgrades Quest Diagnostics to Hold, Announces $135 Price Target

Jefferies analyst Brian Tanquilut downgrades Quest Diagnostics (NYSE:DGX) from Buy to Hold and announces $135 price target.

byBenzinga Newsdesk

February 2, 2022

1 minute read

Jefferies analyst Brian Tanquilut downgrades Quest Diagnostics (NYSE:DGX) from Buy to Hold and announces $135 price target.

Wells Fargo Maintains Overweight on Suncor Energy, Lowers Price Target to C$51

By Benzinga Newsdesk

Today, 10:19 AM

Wells Fargo analyst Roger Read maintains Suncor Energy (TSX:SU) with a Overweight and lowers the price target from C$55 to C$51.

Why NCR Shares Are Trading Higher Today

By Anusuya Lahiri

Today, 10:19 AM

NCR Corp (NYSE:NCR) is amid exclusive talks for sale to private-equity firm Veritas Capital, the Wall Street Journal reports. NCR…

KSS

Goldman Sachs Maintains Neutral on AMC Networks, Lowers Price Target to $28

By Benzinga Newsdesk

Today, 10:19 AM

Goldman Sachs analyst Brett Feldman maintains AMC Networks (NASDAQ:AMCX) with a Neutral and lowers the price target from $32 to $28.

AMCX

The Valens Co. Reaches Third-Largest Cannabis Market In Canada

By Nina Zdinjak

Today, 10:19 AM

Cannabis manufacturer The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) revealed Monday it has reached the Québec cannabis market. The Kelowna, British Columbia-based company executed a letter of intent with Société québécois

TSX:VLNS

Jefferies Downgrades Quest Diagnostics to Hold, Announces $135 Price Target

Related Posts

Wells Fargo Maintains Overweight on Suncor Energy, Lowers Price Target to C$51

Why NCR Shares Are Trading Higher Today

Goldman Sachs Maintains Neutral on AMC Networks, Lowers Price Target to $28

The Valens Co. Reaches Third-Largest Cannabis Market In Canada